Studies with an MSA mouse model showed Anle 138b, an oral general inhibitor of protein aggregation, to be successful in reducing oligomeric α-synuclein concentration and glial cytoplasmic inclusions. This evidence concerns the gene SNCA and multiple system atrophy.